It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers
Cambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impact of Alzheimer's disease.
6 hours ago
0
9